BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12609845)

  • 21. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features.
    Guarini A; Gaidano G; Mauro FR; Capello D; Mancini F; De Propris MS; Mancini M; Orsini E; Gentile M; Breccia M; Cuneo A; Castoldi G; Foa R
    Blood; 2003 Aug; 102(3):1035-41. PubMed ID: 12676780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high mutation rate of immunoglobulin heavy chain variable region gene associates with a poor survival and chemotherapy response of mantle cell lymphoma patients.
    Li X; Wu N; Li B
    Medicine (Baltimore); 2019 May; 98(22):e15811. PubMed ID: 31145313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.
    Clot G; Jares P; Giné E; Navarro A; Royo C; Pinyol M; Martín-Garcia D; Demajo S; Espinet B; Salar A; Ferrer A; Muntañola A; Aymerich M; Rauert-Wunderlich H; Jaffe ES; Connors JM; Gascoyne RD; Delabie J; López-Guillermo A; Ott G; Wright GW; Staudt LM; Rosenwald A; Scott DW; Rimsza LM; Beà S; Campo E
    Blood; 2018 Jul; 132(4):413-422. PubMed ID: 29769262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cutaneous blastoid mantle cell lymphoma-case report.
    Estrozi B; Sanches JA; Varela PC; Bacchi CE
    Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome.
    Molina TJ; Delmer A; Cymbalista F; Le Tourneau A; Perrot JY; Ramond S; Marie JP; Audouin J; Zittoun R; Diebold J
    Virchows Arch; 2000 Dec; 437(6):591-8. PubMed ID: 11193469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
    Del Giudice I; Messina M; Chiaretti S; Santangelo S; Tavolaro S; De Propris MS; Nanni M; Pescarmona E; Mancini F; Pulsoni A; Martelli M; Di Rocco A; Finolezzi E; Paoloni F; Mauro FR; Cuneo A; Guarini A; Foà R
    Br J Haematol; 2012 Mar; 156(5):601-11. PubMed ID: 22150124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blastic mantle cell lymphoma with a Burkitt translocation.
    Reddy K; Ansari-Lari M; Dipasquale B
    Leuk Lymphoma; 2008 Apr; 49(4):740-50. PubMed ID: 18398742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
    Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
    Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material.
    Bentz JS; Rowe LR; Anderson SR; Gupta PK; McGrath CM
    Cancer; 2004 Apr; 102(2):124-31. PubMed ID: 15098257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
    Martínez N; Camacho FI; Algara P; Rodríguez A; Dopazo A; Ruíz-Ballesteros E; Martín P; Martínez-Climent JA; García-Conde J; Menárguez J; Solano F; Mollejo M; Piris MA
    Cancer Res; 2003 Dec; 63(23):8226-32. PubMed ID: 14678979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clonality analysis and mutation status of IgVH genes in classic Richter's syndrome].
    Mao ZR; Rosenwald A; Zhang SJ; Zhou R; Mueller-Hermelink HK
    Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):364-70. PubMed ID: 19031714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
    Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
    Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic variations in mantle cell lymphoma.
    Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
    Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
    Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
    Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
    Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
    Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
    Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U
    J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients.
    Matutes E; Parry-Jones N; Brito-Babapulle V; Wotherspoon A; Morilla R; Atkinson S; Elnenaei MO; Jain P; Giustolisi GM; A'Hern RP; Catovsky D
    Leuk Lymphoma; 2004 Oct; 45(10):2007-15. PubMed ID: 15370245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.